![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 45/06 | |
A61K 31/519 | |||
A61K 31/55 | |||
A61P 35/00 |
(11) | Number of the document | 2713727 |
(13) | Kind of document | T |
(96) | European patent application number | 12793812.4 |
Date of filing the European patent application | 2012-06-04 | |
(97) | Date of publication of the European application | 2014-04-09 |
(45) | Date of publication and mention of the grant of the patent | 2021-03-31 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2012/040733 |
Date | 2012-06-04 |
(87) | Number | WO 2012/167247 |
Date | 2012-12-06 |
(30) | Number | Date | Country code |
201161493217 P | 2011-06-03 | US | |
201261613207 P | 2012-03-20 | US |
(72) |
CHAKRAVARTY, Arijit, US
VINCENT, Patrick, US
|
(73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
Takeda Pharmaceutical Company Ltd., Oncology DDU C-1 2F 1110 26-1 Muraokahigashi 2-chome Fujisawa, Kanagawa 251-0012, JP |
(54) | COMBINATION OF MEK INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE |
COMBINATION OF MEK INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE |